Enanta Pharmaceuticals
ENTA
#7451
Rank
$0.42 B
Marketcap
$14.60
Share price
3.62%
Change (1 day)
82.27%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2025 (TTM): -$86.2 Million USD

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are $64.8 Million USD. In 2024 the company made an earning of -$97.01 Million USD, an increase over its 2023 earnings that were of -$0.13 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -$86.2 Million-11.15%
2024 -$97.01 Million-23.87%
2023 -$0.13 Billion4.39%
2022 -$0.13 Billion-4.4%
2021 -$0.13 Billion91.12%
2020 -$66.81 Million-407.13%
2019 $21.75 M-78.63%
2018 $0.10 B117.97%
2017 $46.7 M-574.65%
2016 -$9.84 Million-110.83%
2015 $90.88 M-4.5%
2014 $95.16 M-638.53%
2013 -$17.68 Million-137.98%
2012 $46.52 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
AbbVie
ABBV
$1.66 B-2,025.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$32.39 B-37,685.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
$4.46 B-5,276.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$23.09 B-26,889.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$8.03 B-9,419.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$16.41 B-19,149.33%๐Ÿ‡จ๐Ÿ‡ญ Switzerland